| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.037 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |